Is CFAP92 p.Pro51Leu (c.152C>T) pathogenic?

CFAP92 p.Pro51Leu (c.152C>T) is classified Uncertain significance in CFAP92 (ClinVar, Single submitter, 1 submitter; last evaluated 2025-03-18). AlphaMissense: likely benign (0.0733); Ultra-rare (popmax 0.0267%, eas).

How common is CFAP92 p.Pro51Leu (c.152C>T) in the general population?

CFAP92 p.Pro51Leu (c.152C>T) is ultra-rare (popmax 0.0267%, eas) (gnomAD).

What do computational predictors say about CFAP92 p.Pro51Leu (c.152C>T)?

AlphaMissense predicts likely benign (score 0.0733) — an in-silico prediction, not a clinical call.

CFAP92 p.Pro51Leu

c.152C>T · VCV4001677

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.0733 · ACMG-weighted

gnomAD v4.1

Rare

ultra-rare (popmax 0.0267%, eas)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.0733	likely benign
REVEL	0.012	strongly benign-leaning
SaProt	LLR -6.22	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -3	GERP -3
Regional constraint	o/e 0.94	unconstrained · MANE · 83 kb · p 0.026 · regional, not allelic
Overall
CADD	0.041	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0267% East Asian · 12/44,886 alleles

Filtering AF 0.0154% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0121%

Overall 0.00589% 95/1,614,066 alleles · ultra-rare

Ancestry group	Frequency	1 in
East Asiangrpmax	0.0267%	3,740
European (non-Finnish)	0.00661%	15,127
Remaining individualsnot grpmax-eligible	0.0064%	15,622
African / African-American	0.00133%	75,068

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: CFAP92
Protein: p.Pro51Leu
Coding: c.152C>T
MANE Select: NM_001394090
Type: single nucleotide variant
Location: chr3:128993153 (GRCh38)
Gene constraint: LOEUF 0.959 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 57.39
Residue 51: the 'disordered' region

Full CFAP92 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

ACAD9 c.1692+1G>A Likely pathogenic ★★ same type
ACAD9 p.Arg532Gln Likely pathogenic ★★ ⚠ same type
ACAD9 p.Asn569His Uncertain significance ★★ ⚠ same type
ACAD9 p.Glu596Lys Uncertain significance ★★ ⚠ same type
ACAD9 c.1692+145G>C Benign ★★ same type
ACAD9 c.*26C>T Benign/Likely benign ★★ same type
ACAD9 c.*331T>G Benign/Likely benign ★★ same type
ACAD9 c.*68C>T Benign/Likely benign ★★ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cfap92-p-pro51leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown